Literature DB >> 9795374

Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid.

T Takeda1, H Kurachi, T Yamamoto, Y Nishio, Y Nakatsuji, K i Morishige, A Miyake, Y Murata.   

Abstract

Cytokines and steroid hormones use different sets of signal transduction pathways, which seem to be unrelated. Interleukin-6 (IL-6) uses JAK tyrosine kinase and STAT (signal transducer and activator of transcription) transcription factor. Glucocorticoid binds glucocorticoid receptor (GR), which is a member of the steroid receptor superfamily. We have studied the crosstalk between the IL-6-JAK-STAT and glucocorticoid-nuclear receptor pathways. IL-6 and glucocorticoid synergistically activated the IL-6 response element on the rat alpha2-macroglobulin promoter (APRE)-driven luciferase gene. The exogenous expression of GR enhanced the synergism. The exogenous expression of dominant negative STAT3 completely abolished the IL-6 plus glucocorticoid-induced activation of the APRE-luciferase gene. Tyrosine phosphorylation of STAT3 stimulated by IL-6 alone was not different from that by IL-6 plus glucocorticoid. The protein level of STAT3 was also not increased by glucocorticoid stimulation. The time course of STAT3 tyrosine phosphorylation by IL-6 plus glucocorticoid was not different from that by IL-6 alone. The synergism was studied on the two other IL-6 response elements, the junB promoter (JRE-IL-6) and the interferon regulatory factor-1 (IRF-1) promoter (IRF-GAS) which could be activated by STAT3. The synergistic activation by glucocorticoid on the IL-6-activated JRE-IL-6 and the IRF-GAS-driven luciferase gene was not detected. Glucocorticoid did not change the mobility of IL-6-induced APRE-binding proteins in a gel shift assay. These results suggest that the synergism was through the GR and STAT3, and the coactivation pathway which was specific for APRE was the target of glucocorticoid.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795374     DOI: 10.1677/joe.0.1590323

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  24 in total

1.  Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5.

Authors:  W Doppler; M Windegger; C Soratroi; J Tomasi; J Lechner; S Rusconi; A C Cato; T Almlöf; J Liden; S Okret; J A Gustafsson ; H Richard-Foy; D B Starr; H Klocker; D Edwards; S Geymayer
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

2.  A novel non-overlapping bi-clustering algorithm for network generation using living cell array data.

Authors:  E Yang; P T Foteinou; K R King; M L Yarmush; I P Androulakis
Journal:  Bioinformatics       Date:  2007-09-07       Impact factor: 6.937

3.  NETWORKS, BIOLOGY AND SYSTEMS ENGINEERING: A CASE STUDY IN INFLAMMATION.

Authors:  P T Foteinou; E Yang; I P Androulakis
Journal:  Comput Chem Eng       Date:  2009-12-10       Impact factor: 3.845

4.  MUC16 Regulates TSPYL5 for Lung Cancer Cell Growth and Chemoresistance by Suppressing p53.

Authors:  Imayavaramban Lakshmanan; Shereen Salfity; Parthasarathy Seshacharyulu; Satyanarayana Rachagani; Abigail Thomas; Srustidhar Das; Prabin D Majhi; Rama Krishna Nimmakayala; Raghupathy Vengoji; Subodh M Lele; Moorthy P Ponnusamy; Surinder K Batra; Apar Kishor Ganti
Journal:  Clin Cancer Res       Date:  2017-02-14       Impact factor: 12.531

5.  The type I interferon signaling pathway is a target for glucocorticoid inhibition.

Authors:  Jamie R Flammer; Jana Dobrovolna; Megan A Kennedy; Yurii Chinenov; Christopher K Glass; Lionel B Ivashkiv; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

6.  Influenza virus infection induces metallothionein gene expression in the mouse liver and lung by overlapping but distinct molecular mechanisms.

Authors:  K Ghoshal; S Majumder; Q Zhu; J Hunzeker; J Datta; M Shah; J F Sheridan; S T Jacob
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner.

Authors:  Hirokazu Okada; Tomohiro Kikuta; Tsutomu Inoue; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masaharu Takigawa; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

8.  Deciphering the regulatory logic of an ancient, ultraconserved nuclear receptor enhancer module.

Authors:  Pia D Bagamasbad; Ronald M Bonett; Laurent Sachs; Nicolas Buisine; Samhitha Raj; Joseph R Knoedler; Yasuhiro Kyono; Yijun Ruan; Xiaoan Ruan; Robert J Denver
Journal:  Mol Endocrinol       Date:  2015-04-13

9.  Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug.

Authors:  Samaresh Sau; Sujan Kumar Mondal; Sushil K Kashaw; Arun K Iyer; Rajkumar Banerjee
Journal:  Mol Cell Biochem       Date:  2017-06-05       Impact factor: 3.396

10.  Induction of the upstream regulatory region of human papillomavirus type 31 by dexamethasone is differentiation dependent.

Authors:  Jennifer L Bromberg-White; Ellora Sen; Samina Alam; Jason M Bodily; Craig Meyers
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.